相关实验视频

Updated: Jun 21, 2025

Associated Chromosome Trap for Identifying Long-range DNA Interactions

Associated Chromosome Trap for Identifying Long-range DNA Interactions

Published on: April 23, 2011

在CML和BCR中基因组突破点的明显模式:ABL1-阳性ALL:对971名患者的分析

Lenka Hovorkova^1,2, Lucie Winkowska^1,2, Justina Skorepova^1,2

¹CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.

Molecular cancer

|July 5, 2024

概括

白血病中的BCR::ABL1融合基因断点显示非随机分布,在CML和ALL之间存在差异. 染色体可访问性和细胞发育,而不是DNA动机,影响断点定位.

科学领域:

遗传学和基因组学在
分子生物学分子生物学
癌症研究癌症研究

背景情况:

BCR::ABL1融合基因是慢性髓性白血病 (CML) 和急性淋巴细胞白血病 (ALL) 的关键驱动因素.
在BCR中发生在主要和次要区域的基因组断裂,形成p210和p190融合蛋白.
了解断点模式对于白血病的诊断和治疗至关重要.

关键词:

ABL1 ABL1 ABL1 ABL1 ABL1 ABL1 ABL1 ABL1 ABL1 ABL1 ABL1 急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.在BCR中,BCR是指BCR.慢性骨髓性白血病慢性骨髓性白血病基因组的断点基因组的断点

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...